Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is solifenacin succinate safe and effective for the treatment of overactive bladder?

Nature Clinical Practice Urology volume 5, pages 128–129 (2008)Cite this article

boxed-textYamaguchi O et al. (2007) Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int 100: 579–587

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Abrams P et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37–49

    Article  Google Scholar 

  2. Chapple CR et al. (2005) A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48: 464–470

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. 2080 Century Park East, Suite 1407, Los Angeles, CA 90067, USA karyn.eilber@cshs.org

Authors and Affiliations

  1. and Clinical Instructor in Urology at the Division of Urology, KS Eilber is Director at the Century Institute for Continence, Harbor-University of California, Los Angeles Medical Center, Los Angeles, CA, USA.,

    Karyn S Eilber

Authors
  1. Karyn S Eilber
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Karyn S Eilber has received grants/research support from Astellas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eilber, K. Is solifenacin succinate safe and effective for the treatment of overactive bladder?. Nat Rev Urol 5, 128–129 (2008). https://doi.org/10.1038/ncpuro1040

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1040

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing